Somerset Theraps Llc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SOMERSET THERAPS LLC
SOMERSET THERAPS LLC has eighty approved drugs.
Drugs and US Patents for Somerset Theraps Llc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Somerset Theraps Llc | BEPOTASTINE BESILATE | bepotastine besilate | SOLUTION/DROPS;OPHTHALMIC | 217770-001 | Aug 14, 2024 | AT | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Somerset Theraps Llc | VARENICLINE TARTRATE | varenicline tartrate | TABLET;ORAL | 219382-001 | Jul 6, 2026 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Somerset Theraps Llc | DROXIDOPA | droxidopa | CAPSULE;ORAL | 214543-002 | May 5, 2021 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Somerset Theraps Llc | FAMOTIDINE | famotidine | FOR SUSPENSION;ORAL | 217655-001 | Jun 16, 2023 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Somerset Theraps Llc | TERIFLUNOMIDE | teriflunomide | TABLET;ORAL | 209702-002 | Feb 28, 2020 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

